Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CO/Denver
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Denver, CO

Studies commonly pay $75 to $4,500 per completed study

1,599 clinical trials are currently recruiting participants within 30 miles of Denver. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,599studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Denver right now

Top 25 of 1,599 recruiting studies, sorted by proximity — each links to its official registry page

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis N/A Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (6.0 mi) · Sponsor: University of Colorado, Denver

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG Phase 2 Interventional 60 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi) · Sponsor: Nationwide Children's Hospital

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Ovarian Cancer, Advanced Ovarian Carcinoma N/A Interventional 240 participants sought
University of Colorado Cancer Center-Anschutz — Aurora, Colorado (3.2 mi) · Sponsor: Dana-Farber Cancer Institute

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Denver, Colorado (6.0 mi) · Sponsor: Avenzo Therapeutics, Inc.

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Phase 1 Interventional 248 participants sought
Sarah Cannon Research Institute at Colorado Blood Cancer Institute — Denver, Colorado (6.0 mi) · Sponsor: Nurix Therapeutics, Inc.

Creative Arts Program to Reduce Burnout in Healthcare Professionals

Burn-Out Syndrome, Post-Traumatic Stress Disorder N/A Interventional 195 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (3.2 mi) · Sponsor: University of Colorado, Denver

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi) · Sponsor: Novartis Pharmaceuticals

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Rocky Mountain Lions Eye Institute — Aurora, Colorado (3.2 mi) · Sponsor: Astellas Pharma Global Development, Inc.

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC) Phase 1 Interventional 30 participants sought
SCRI at HCA HealthONE — Denver, Colorado (6.0 mi) · Sponsor: SHY Therapeutics

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection Phase 2 Interventional 84 participants sought
University of Colorado at Denver ( Site 0108) — Aurora, Colorado (3.2 mi) · Sponsor: Merck Sharp & Dohme LLC

Type 1 Diabetes Extension Study

Type 1 Diabetes Mellitus, T1DM N/A Observational 111 participants sought
University of Colorado School of Medicine: Barbara Davis Center for Diabetes — Aurora, Colorado (3.2 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Esophageal Cancer, Head and Neck Cancer N/A Observational 700 participants sought
University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado (3.2 mi) · Sponsor: University of Colorado, Denver

SynKIR-310 for Relapsed/Refractory B-NHL

B Cell Lymphoma, NHL, Adult Phase 1 Interventional 36 participants sought
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute — Denver, Colorado (6.0 mi) · Sponsor: Verismo Therapeutics

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Knee Cartilage Defects Phase 3 Interventional 300 participants sought
Orthopedic Centers of Colorado — Parker, Colorado (17.9 mi) · Sponsor: Medipost, Inc.

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis, Amyloid Cardiomyopathy Phase 3 Interventional 587 participants sought
University of Colorado Anschutz — Aurora, Colorado (3.2 mi) · Sponsor: Eidos Therapeutics, a BridgeBio company

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Sarcoma Phase 2 Interventional 20 participants sought
University Of Colorado Hospital — Aurora, Colorado (3.2 mi) · Sponsor: University of Colorado, Denver

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
Colorado Clinical Research — Lakewood, Colorado (11.6 mi) · Sponsor: Janssen Research & Development, LLC

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Denver, Colorado (6.0 mi) · Sponsor: AstraZeneca
Google-rated

Top-rated research centers in Denver

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

CPC Clinical Research & Community Health

★ 4.0
2115 N Scranton St Ste 2040, Aurora, CO 80045
(303) 860-9900
"We are truly blessed to be apart of their patients. My son sees the Hematology office here and since we are newer to this diagnosis and health condit…"
— Missy R., 5★

Colorado Clinical and Translational Sciences Institute (CCTSI) – Anschutz Medical Campus

1890 N Revere Ct, Aurora, CO 80045
(303) 724-1222

Tekton Research

★ 5.0
2373 Central Park Blvd Unit 300, Denver, CO 80238
(303) 970-9777
"I had excellent experiences during both of the studies I participated in. Both Jessica and Dr. Davidson are thoughtful, thorough and professional but…"
— Karstyn Butler, 5★

Denver Research Institute

3401 Quebec St #5000, Denver, CO 80207
(720) 457-0670

Mountain View Clinical Research

★ 4.3
3955 E Exposition Ave #104, Denver, CO 80209
(720) 941-9363
"Such a great organization with helpful, knowledgeable staff!"
— Windsong Forrest, 5★

Centennial Clinical Trials

469 S Cherry St #101, Denver, CO 80246
(720) 961-1952

Gates Institute

★ 5.0
Mailstop L606, 1890 N Revere Ct, Aurora, CO 80045
(303) 724-1274

Advanced Research Institute - Denver

★ 5.0
1830 Franklin St Ste 220, Denver, CO 80218
(303) 353-2660

Sussel Lab

1775 Aurora Ct, Aurora, CO 80045
(303) 724-9119

Clinical trials in Denver: what's recruiting

The Denver area currently has 1,599 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Denver, the most active research areas are:

  • Cancer & Oncology10 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney2 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Denver, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Denver

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Denver participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Denver pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Denver safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Denver, CO?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Denver?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Denver.

Paid clinical trials near Denver

Other metros within reach

More of CO

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts